ANTHEM BIOSCIENCES LIMITED

14 Jul 2025 - 16 Jul 2025 Individual Category Main Board BSE NSE

Min Investment

₹14820

Price Band

₹540-₹570

Issue Size

440.71 lakhs
Equity Shares

Lot Size

26 (per lot)

IPO Dates
img

14 Jul 2025

Open Date

img

16 Jul 2025

Close Date

img

17 Jul 2025

Allotment Date

img

21 Jul 2025

Listing Date

Anthem Biosciences IPO open date is July 14 and IPO closing date is July 16, 2025. This new IPO is a book-built issue of 4.41 crore equity shares. This upcoming IPO is offering an entirely offer for sale.Anthem Biosciences IPO price band is Rs 540 to Rs 570 per share. As of now, Anthem Biosciences IPO GMP Live is at Rs 133. Live IPO Grey Market Premium details is visible online.Anthem Biosciences IPO allotment status is finalised on July 17, 2025. The lot size is 26 shares. The minimum investment for retail investors is 1 lot, amounting to Rs 14,820. The registrar for Anthem Biosciences IPO is Kfin Technologies Limited. The listing date is July 21, 2025.

Know Before Investing

Strengths icon

  • Fastest Indian CRDMO to surpass ₹1000 Cr revenue in just 14 years.
  • Provides end-to-end CRDMO solutions for both small molecules and biologics.
  • Taps high-growth areas like GLP-1 and biosimilars.

Weaknesses icon

  • Top 10 clients contribute 76.75% revenue—loss could impact business.
  • Regulatory issues could block exports and damage credibility.
  • Plant closures or accidents may disrupt output and affect revenue.

About Anthem Biosciences Limited

Anthem Biosciences Limited, established in 2006 in Bangalore, India, is a major Contract Research and Development Organization (CRDMO). The company specialises in drug discovery, development, and manufacturing services, catering to large pharmaceutical firms globally. The company has a team of over 1,200 scientists. Anthem offers a various range of services including medicinal chemistry, process development, and analytical research. Their facilities are equipped with advanced technology and have received approvals from regulatory bodies such as the USFDA and TGA. Anthem has demonstrated strong financial health, characterised by impressive margins and liquidity. As it continues to expand its capabilities, Anthem remains committed to innovation and quality in the biopharmaceutical sector, ensuring timely delivery and compliance with industry standards.

Founded

2006

Managing Director

Ajay Bhardwaj

Parent Organization

-

IPO Objectives

Since the offer is an Offer for Sale, the company will not receive any proceeds from the offer. The funds received from IPO will get directly credited to the bank account of the respective selling shareholders.

Company Promoters

Ajay Bhardwaj

Ganesh Sambasivam

K Ravindra Chandrappa

Ishaan Bhardwaj

Subscription Details

Investor Category Subscription (times)
Qualified Institutions 0
Non-Institutional Buyers 0
bNII (bids above ₹10L) 0
sNII (bids below ₹10L) 0
Retail Investors 0
Employees 0
Others 0
Total 0
img

How to Apply for IPO

img img

Login

Login to your Bigul Account

Select Lots & Price

Choose the number of lots and price

UPI ID

Enter your UPI ID

UPI Mandate Request

A UPI Mandate Request Triggered

Approve Mandate

Approve the UPI Mandate Request

IPO Allotment

YES Share will be credited. and the amount will be debited

Close

Let's Open Free Demat Account